JP Morgan Maintains Overweight on IDEAYA Biosciences, Raises Price Target to $32
Portfolio Pulse from richadhand@benzinga.com
JP Morgan analyst Anupam Rama maintains an Overweight rating on IDEAYA Biosciences (NASDAQ:IDYA) and raises the price target from $28 to $32.
August 17, 2023 | 2:31 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
JP Morgan maintains an Overweight rating on IDEAYA Biosciences and raises the price target from $28 to $32.
The news of JP Morgan maintaining an Overweight rating on IDEAYA Biosciences and raising the price target from $28 to $32 is likely to have a positive impact on the company's stock in the short term. This is because such an announcement from a reputable financial institution like JP Morgan can boost investor confidence in the company, potentially leading to an increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100